{"transactions":[{"id":695529,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-05T20:01:39.000Z","date":"2026-08-04","kind":"sale","planned":false,"acquired":false,"shares":43947,"price":2.4598,"value":108100.8306,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 75,000 shares of Common Stock underlying RSUs granted to the Reporting Person on July 29, 2024. These sales were automatically executed pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through \"sell-to-cover\" transactions and were not made at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $2.415 to $2.540 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":591815,"source":{"system":"sec-edgar","filing":"0001193125-26-335007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000119312526335007/ownership.xml","form_type":"4"}},{"id":767794,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-05-21T20:01:08.000Z","date":"2026-05-20","kind":"sale","planned":false,"acquired":false,"shares":28946,"price":1.8822,"value":54482.1612,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 50,000 shares of Common Stock underlying performance-based RSUs granted to the Reporting Person on July 29, 2024. These sales were automatically executed pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through \"sell-to-cover\" transactions and were not made at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $1.825 to $1.935 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":635762,"source":{"system":"sec-edgar","filing":"0001193125-26-234380","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000119312526234380/ownership.xml","form_type":"4"}},{"id":937104,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-16T21:00:59.000Z","date":"2026-01-15","kind":"grant","planned":false,"acquired":true,"shares":1300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2026, such that all of the shares shall be fully vested and exercisable on January 1, 2029, subject to the Reporting Person's continued service with the Issuer as of each such vesting date."}],"balance_after":1300000,"derivative":{"exercise_price":1.05,"expiration_date":"2036-01-14","underlying":"Common Stock","underlying_shares":1300000},"source":{"system":"sec-edgar","filing":"0001193125-26-015294","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000119312526015294/ownership.xml","form_type":"4"}},{"id":937103,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-01-16T21:00:59.000Z","date":"2026-01-15","kind":"grant","planned":false,"acquired":true,"shares":335000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of restricted stock units (\"RSUs\") that vest with respect to 1/4th of the RSUs on each of January 8, 2027, January 8, 2028, January 8, 2029 and January 8, 2030, subject to the Reporting Person's continued service with the Issuer as of each such vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement."}],"balance_after":664708,"source":{"system":"sec-edgar","filing":"0001193125-26-015294","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000119312526015294/ownership.xml","form_type":"4"}},{"id":940907,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-01-12T21:03:31.000Z","date":"2026-01-09","kind":"sale","planned":false,"acquired":false,"shares":5190,"price":1.0708,"value":5557.452,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 8,326 shares of Common Stock underlying RSUs granted to the Reporting Person on January 25, 2022. These sales were automatically executed pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through \"sell-to-cover\" transactions and were not made at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $1.055 to $1.085 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":329708,"source":{"system":"sec-edgar","filing":"0001193125-26-010352","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000119312526010352/ownership.xml","form_type":"4"}},{"id":1074395,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-08-05T20:02:34.000Z","date":"2025-08-04","kind":"sale","planned":false,"acquired":false,"shares":14466,"price":1.0643,"value":15396.1638,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 25,000 shares of Common Stock underlying RSUs granted to the Reporting Person on July 29, 2024. These sales were automatically executed pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through \"sell-to-cover\" transactions and were not made at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $1.04 to $1.07 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":334898,"source":{"system":"sec-edgar","filing":"0000950170-25-102979","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000095017025102979/ownership.xml","form_type":"4"}},{"id":1301420,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-16T23:36:35.000Z","date":"2025-01-16","kind":"grant","planned":false,"acquired":true,"shares":1300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2025, such that all of the shares shall be fully vested and exercisable on January 1, 2028, subject to the Reporting Person's continued service with the Issuer as of each such vesting date."}],"balance_after":1300000,"derivative":{"exercise_price":1.25,"expiration_date":"2035-01-15","underlying":"Common Stock","underlying_shares":1300000},"source":{"system":"sec-edgar","filing":"0000950170-25-006318","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000095017025006318/ownership.xml","form_type":"4"}},{"id":1304260,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-13T21:04:38.000Z","date":"2025-01-10","kind":"sale","planned":false,"acquired":false,"shares":8705,"price":1.54,"value":13405.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 4,504 shares of Common Stock underlying RSUs granted to the Reporting Person on January 20, 2021 and 8,325 shares of Common Stock underlying RSUs granted to the Reporting Person on January 25, 2022. These sales were made pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through \"sell to cover\" transactions and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $1.51 to $1.62 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":349364,"source":{"system":"sec-edgar","filing":"0000950170-25-004814","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000095017025004814/ownership.xml","form_type":"4"}},{"id":1445227,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2024-07-31T22:05:23.000Z","date":"2024-07-29","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were granted pursuant to a restricted stock unit award.  100,000 of the units are subject to time-based vesting and 100,000 of the units are subject to performance-based vesting.  25,000 time-based units will vest on August 1, 2025 and 75,000 time-based units will vest on August 1, 2026, so long as the reporting person continues to serve as an employee of the issuer through each vesting date. Subject to the achievement of specified late-stage clinical and regulatory milestones of the issuer on or before July 29, 2028, half of the performance-based units will vest one year after the achievement of two of three of the milestones, and the remaining 50,000 of the performance-based units will vest on the date one year after the achievement of all three of the milestones, in each case subject to the grantee's continued employment with the issuer through each such vesting date."}],"balance_after":358069,"source":{"system":"sec-edgar","filing":"0000950170-24-088775","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000095017024088775/ownership.xml","form_type":"4"}},{"id":1661467,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-02T21:09:29.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2024, such that all of the shares shall be fully vested and exercisable on January 1, 2027, subject to the Reporting Person's continued service with the Issuer as of each such vesting date."}],"balance_after":450000,"derivative":{"exercise_price":6.76,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0000950170-24-010484","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000095017024010484/ownership.xml","form_type":"4"}},{"id":1681525,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2024-01-10T21:30:15.000Z","date":"2024-01-09","kind":"sale","planned":false,"acquired":false,"shares":11271,"price":4.38,"value":49366.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the Reporting Person on January 8, 2020, 4,503 shares of Common Stock underlying RSUs granted to the Reporting Person on January 20, 2021, and 8,326 shares of Common Stock underlying RSUs granted to the Reporting Person on January 25, 2022. These sales were made pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through \"sell to cover\" transactions and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $4.01 to $4.50 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":158069,"source":{"system":"sec-edgar","filing":"0000950170-24-003650","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000095017024003650/ownership.xml","form_type":"4"}},{"id":2028301,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-07T21:20:09.000Z","date":"2023-02-06","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2023, such that all of the shares shall be fully vested and exercisable on January 1, 2026, subject to the Reporting Person's continued service with the Issuer as of each such vesting date."}],"balance_after":450000,"derivative":{"exercise_price":6.77,"expiration_date":"2033-02-05","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001209191-23-007511","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919123007511/doc4.xml","form_type":"4"}},{"id":2054650,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-13T21:02:47.000Z","date":"2023-01-12","kind":"exercise","acquired":true,"shares":423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.37,"expiration_date":"2023-01-14","underlying":"Common Stock","underlying_shares":423},"source":{"system":"sec-edgar","filing":"0001209191-23-003261","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919123003261/doc4.xml","form_type":"4"}},{"id":2054649,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2023-01-13T21:02:47.000Z","date":"2023-01-12","kind":"exercise","acquired":true,"shares":423,"price":1.37,"value":579.51,"ownership":{"direct":true},"balance_after":169340,"source":{"system":"sec-edgar","filing":"0001209191-23-003261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919123003261/doc4.xml","form_type":"4"}},{"id":2056413,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2023-01-11T21:08:52.000Z","date":"2023-01-10","kind":"sale","acquired":false,"shares":10917,"price":5.24,"value":57205.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the Reporting Person on January 8, 2020, 4,503 shares of Common Stock underlying RSUs granted to the Reporting Person on January 20, 2021, and 8,325 shares of Common Stock underlying RSUs granted to the Reporting Person on January 25, 2022. These sales were made pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through \"sell to cover\" transactions and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $5.12 to $5.36 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":168917,"source":{"system":"sec-edgar","filing":"0001209191-23-002978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919123002978/doc4.xml","form_type":"4"}},{"id":2209812,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-08T20:51:04.000Z","date":"2022-07-07","kind":"exercise","acquired":false,"shares":17158,"price":2.73,"value":46841.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":13156,"derivative":{"exercise_price":2.73,"expiration_date":"2027-01-04","underlying":"Common Stock","underlying_shares":17158},"source":{"system":"sec-edgar","filing":"0001209191-22-041670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122041670/doc4.xml","form_type":"4"}},{"id":2209811,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-07-08T20:51:04.000Z","date":"2022-07-07","kind":"sale","acquired":false,"shares":17158,"price":30.23,"value":518686.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $30.00 to $30.53 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range set forth in footnote 2."}],"balance_after":179834,"source":{"system":"sec-edgar","filing":"0001209191-22-041670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122041670/doc4.xml","form_type":"4"}},{"id":2209810,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-07-08T20:51:04.000Z","date":"2022-07-07","kind":"exercise","acquired":true,"shares":17158,"price":2.73,"value":46841.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2020."}],"balance_after":196992,"source":{"system":"sec-edgar","filing":"0001209191-22-041670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122041670/doc4.xml","form_type":"4"}},{"id":2210688,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-07T20:04:11.000Z","date":"2022-07-06","kind":"exercise","acquired":false,"shares":5842,"price":2.73,"value":15948.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":30314,"derivative":{"exercise_price":2.73,"expiration_date":"2027-01-04","underlying":"Common Stock","underlying_shares":5842},"source":{"system":"sec-edgar","filing":"0001209191-22-041440","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122041440/doc4.xml","form_type":"4"}},{"id":2210687,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-07T20:04:11.000Z","date":"2022-07-06","kind":"exercise","acquired":false,"shares":2000,"price":4.84,"value":9680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":8704,"derivative":{"exercise_price":4.84,"expiration_date":"2025-01-05","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-22-041440","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122041440/doc4.xml","form_type":"4"}},{"id":2210686,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-07-07T20:04:11.000Z","date":"2022-07-06","kind":"sale","acquired":false,"shares":7842,"price":30.07,"value":235808.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $30.00 to $30.20 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range set forth in footnote 2."}],"balance_after":179834,"source":{"system":"sec-edgar","filing":"0001209191-22-041440","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122041440/doc4.xml","form_type":"4"}},{"id":2210685,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-07-07T20:04:11.000Z","date":"2022-07-06","kind":"exercise","acquired":true,"shares":5842,"price":2.73,"value":15948.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2020."}],"balance_after":187676,"source":{"system":"sec-edgar","filing":"0001209191-22-041440","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122041440/doc4.xml","form_type":"4"}},{"id":2210684,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-07-07T20:04:11.000Z","date":"2022-07-06","kind":"exercise","acquired":true,"shares":2000,"price":4.84,"value":9680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2020."}],"balance_after":181834,"source":{"system":"sec-edgar","filing":"0001209191-22-041440","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122041440/doc4.xml","form_type":"4"}},{"id":2333143,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-15T20:27:17.000Z","date":"2022-03-14","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option is fully vested."}],"balance_after":36156,"derivative":{"exercise_price":2.73,"expiration_date":"2027-01-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-018820","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122018820/doc4.xml","form_type":"4"}},{"id":2333142,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-03-15T20:27:17.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":100,"price":34.04,"value":3404.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2020."}],"balance_after":179834,"source":{"system":"sec-edgar","filing":"0001209191-22-018820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122018820/doc4.xml","form_type":"4"}},{"id":2333141,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-03-15T20:27:17.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":2960,"price":33.3,"value":98568.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of the shares sold from $33.00 to $33.91 per share."}],"balance_after":179934,"source":{"system":"sec-edgar","filing":"0001209191-22-018820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122018820/doc4.xml","form_type":"4"}},{"id":2333140,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-03-15T20:27:17.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":2195,"price":32.49,"value":71315.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold from $32.00 to $32.99 per share."}],"balance_after":182894,"source":{"system":"sec-edgar","filing":"0001209191-22-018820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122018820/doc4.xml","form_type":"4"}},{"id":2333139,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-03-15T20:27:17.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":3067,"price":31.66,"value":97101.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold from $31.00 to $31.99 per share."}],"balance_after":185089,"source":{"system":"sec-edgar","filing":"0001209191-22-018820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122018820/doc4.xml","form_type":"4"}},{"id":2333138,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-03-15T20:27:17.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":16678,"price":30.36,"value":506344.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $30.00 to $30.98 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 5."}],"balance_after":188156,"source":{"system":"sec-edgar","filing":"0001209191-22-018820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122018820/doc4.xml","form_type":"4"}},{"id":2333137,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-03-15T20:27:17.000Z","date":"2022-03-14","kind":"exercise","acquired":true,"shares":25000,"price":2.73,"value":68250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2020."}],"balance_after":204834,"source":{"system":"sec-edgar","filing":"0001209191-22-018820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122018820/doc4.xml","form_type":"4"}},{"id":2423984,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-27T21:38:56.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":53058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in 48 equal month installments beginning on February 1, 2022 such that this option will be fully exercisable on January 1, 2026, subject to the Reporting Person's continued service with the Issuer as of each such date."}],"balance_after":53058,"derivative":{"exercise_price":39.87,"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":53058},"source":{"system":"sec-edgar","filing":"0000899243-22-003449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924322003449/doc4.xml","form_type":"4"}},{"id":2423983,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-01-27T21:38:56.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":33302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Award of restricted stock units that vest with respect to 1/4th of the underlying shares on each of January 8, 2023, January 8, 2024, January 8, 2025 and January 8, 2026, subject to the Reporting Person's continued service with the Issuer as of each such date."}],"balance_after":179834,"source":{"system":"sec-edgar","filing":"0000899243-22-003449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924322003449/doc4.xml","form_type":"4"}},{"id":2435883,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-01-13T21:07:15.000Z","date":"2022-01-11","kind":"sale","acquired":false,"shares":418,"price":49.12,"value":20532.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the reporting person on January 8, 2020 and 4,503 shares of Common Stock underlying RSUs granted to the reporting person on January 20, 2021. These sales were made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through \"sell to cover\" transactions and do not represent discretionary trades by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $48.83 to $49.25 per share."}],"balance_after":146532,"source":{"system":"sec-edgar","filing":"0001209191-22-003170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122003170/doc4.xml","form_type":"4"}},{"id":2435882,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-01-13T21:07:15.000Z","date":"2022-01-11","kind":"sale","acquired":false,"shares":4152,"price":48.44,"value":201122.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the reporting person on January 8, 2020 and 4,503 shares of Common Stock underlying RSUs granted to the reporting person on January 20, 2021. These sales were made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through \"sell to cover\" transactions and do not represent discretionary trades by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $47.76 to $48.70 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 3."}],"balance_after":146950,"source":{"system":"sec-edgar","filing":"0001209191-22-003170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122003170/doc4.xml","form_type":"4"}},{"id":2436735,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-01-12T21:05:42.000Z","date":"2022-01-10","kind":"sale","acquired":false,"shares":351,"price":47.17,"value":16556.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 15,000 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $46.77 to $47.42 per share."}],"balance_after":151102,"source":{"system":"sec-edgar","filing":"0001209191-22-003047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122003047/doc4.xml","form_type":"4"}},{"id":2436734,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-01-12T21:05:42.000Z","date":"2022-01-10","kind":"sale","acquired":false,"shares":5245,"price":46.33,"value":243000.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 15,000 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $45.71 to $46.65 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 3."}],"balance_after":151453,"source":{"system":"sec-edgar","filing":"0001209191-22-003047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122003047/doc4.xml","form_type":"4"}},{"id":2473301,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-14T21:18:00.000Z","date":"2021-12-13","kind":"exercise","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option is fully vested."}],"balance_after":61156,"derivative":{"exercise_price":2.73,"expiration_date":"2027-01-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-069415","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121069415/doc4.xml","form_type":"4"}},{"id":2473300,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2021-12-14T21:18:00.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":1600,"price":49.27,"value":78832.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of the shares sold from $49.21 to $49.40 per share."}],"balance_after":156698,"source":{"system":"sec-edgar","filing":"0001209191-21-069415","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121069415/doc4.xml","form_type":"4"}},{"id":2473299,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2021-12-14T21:18:00.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":7718,"price":48.75,"value":376252.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of the shares sold from $48.21 to $49.20 per share."}],"balance_after":158298,"source":{"system":"sec-edgar","filing":"0001209191-21-069415","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121069415/doc4.xml","form_type":"4"}},{"id":2473298,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2021-12-14T21:18:00.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":6564,"price":47.61,"value":312512.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold from $47.21 to $48.20 per share."}],"balance_after":166016,"source":{"system":"sec-edgar","filing":"0001209191-21-069415","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121069415/doc4.xml","form_type":"4"}},{"id":2473297,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2021-12-14T21:18:00.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":7018,"price":46.72,"value":327880.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold from $46.20 to $47.17 per share."}],"balance_after":172580,"source":{"system":"sec-edgar","filing":"0001209191-21-069415","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121069415/doc4.xml","form_type":"4"}},{"id":2473296,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2021-12-14T21:18:00.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":2100,"price":45.68,"value":95928.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $45.18 to $46.17 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 6."}],"balance_after":179598,"source":{"system":"sec-edgar","filing":"0001209191-21-069415","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121069415/doc4.xml","form_type":"4"}},{"id":2473295,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2021-12-14T21:18:00.000Z","date":"2021-12-13","kind":"exercise","acquired":true,"shares":25000,"price":2.73,"value":68250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."}],"balance_after":181698,"source":{"system":"sec-edgar","filing":"0001209191-21-069415","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121069415/doc4.xml","form_type":"4"}},{"id":2500632,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2021-11-22T22:44:08.000Z","date":"2021-11-19","kind":"grant","acquired":true,"shares":60958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were granted pursuant to a performance-based restricted stock unit award. The units will vest in three approximately equal installments conditioned upon the achievement, on or before December 31, 2026, of up to three specified late-stage clinical and regulatory milestones of the issuer, so long as the reporting person continues to serve as an employee of the issuer through each milestone achievement."}],"balance_after":156698,"source":{"system":"sec-edgar","filing":"0001209191-21-066165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121066165/doc4.xml","form_type":"4"}},{"id":2570664,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-14T20:01:27.000Z","date":"2021-09-13","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested."}],"balance_after":86156,"derivative":{"exercise_price":2.73,"expiration_date":"2027-01-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-055867","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121055867/doc4.xml","form_type":"4"}},{"id":2570663,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-09-14T20:01:27.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":800,"price":67.456,"value":53964.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold from $67.40 to $67.54 per share."}],"balance_after":95740,"source":{"system":"sec-edgar","filing":"0001209191-21-055867","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121055867/doc4.xml","form_type":"4"}},{"id":2570662,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-09-14T20:01:27.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":8391,"price":66.8429,"value":560878.7739,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold from $66.40 to $67.38 per share."}],"balance_after":96540,"source":{"system":"sec-edgar","filing":"0001209191-21-055867","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121055867/doc4.xml","form_type":"4"}},{"id":2570661,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-09-14T20:01:27.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":15809,"price":65.938,"value":1042413.842,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $65.40 to $66.38 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 4."}],"balance_after":104931,"source":{"system":"sec-edgar","filing":"0001209191-21-055867","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121055867/doc4.xml","form_type":"4"}},{"id":2570660,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-09-14T20:01:27.000Z","date":"2021-09-13","kind":"exercise","acquired":true,"shares":25000,"price":2.73,"value":68250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."}],"balance_after":120740,"source":{"system":"sec-edgar","filing":"0001209191-21-055867","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121055867/doc4.xml","form_type":"4"}},{"id":2666136,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-16T20:26:36.000Z","date":"2021-06-14","kind":"exercise","acquired":false,"shares":8844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested."}],"balance_after":111156,"derivative":{"exercise_price":2.73,"expiration_date":"2027-01-04","underlying":"Common Stock","underlying_shares":8844},"source":{"system":"sec-edgar","filing":"0001209191-21-040914","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121040914/doc4.xml","form_type":"4"}},{"id":2666135,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-16T20:26:36.000Z","date":"2021-06-14","kind":"exercise","acquired":false,"shares":16156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.9,"expiration_date":"2026-01-08","underlying":"Common Stock","underlying_shares":16156},"source":{"system":"sec-edgar","filing":"0001209191-21-040914","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121040914/doc4.xml","form_type":"4"}},{"id":2666134,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-06-16T20:26:36.000Z","date":"2021-06-14","kind":"sale","acquired":false,"shares":400,"price":90.7575,"value":36303.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold from $90.71 to $90.86 per share."}],"balance_after":95740,"source":{"system":"sec-edgar","filing":"0001209191-21-040914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121040914/doc4.xml","form_type":"4"}},{"id":2666133,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-06-16T20:26:36.000Z","date":"2021-06-14","kind":"sale","acquired":false,"shares":8220,"price":89.6782,"value":737154.804,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold from $89.45 to $90.16 per share."}],"balance_after":96140,"source":{"system":"sec-edgar","filing":"0001209191-21-040914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121040914/doc4.xml","form_type":"4"}},{"id":2666132,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-06-16T20:26:36.000Z","date":"2021-06-14","kind":"sale","acquired":false,"shares":16380,"price":89.1079,"value":1459587.402,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $88.45 to $89.44 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 4."}],"balance_after":104360,"source":{"system":"sec-edgar","filing":"0001209191-21-040914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121040914/doc4.xml","form_type":"4"}},{"id":2666131,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-06-16T20:26:36.000Z","date":"2021-06-14","kind":"exercise","acquired":true,"shares":8844,"price":2.73,"value":24144.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."}],"balance_after":120740,"source":{"system":"sec-edgar","filing":"0001209191-21-040914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121040914/doc4.xml","form_type":"4"}},{"id":2666130,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-06-16T20:26:36.000Z","date":"2021-06-14","kind":"exercise","acquired":true,"shares":16156,"price":2.9,"value":46852.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."}],"balance_after":111896,"source":{"system":"sec-edgar","filing":"0001209191-21-040914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121040914/doc4.xml","form_type":"4"}},{"id":2786060,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-16T20:05:19.000Z","date":"2021-03-15","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option is fully vested."}],"balance_after":16156,"derivative":{"exercise_price":2.9,"expiration_date":"2026-01-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-21-011920","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321011920/doc4.xml","form_type":"4"}},{"id":2786059,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-03-16T20:05:19.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":1018,"price":94.5944,"value":96297.0992,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of the shares sold from $94.40 to $94.90 per share."}],"balance_after":95740,"source":{"system":"sec-edgar","filing":"0000899243-21-011920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321011920/doc4.xml","form_type":"4"}},{"id":2786058,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-03-16T20:05:19.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":3205,"price":93.7475,"value":300460.7375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of the shares sold from $93.31 to $94.29 per share."}],"balance_after":96758,"source":{"system":"sec-edgar","filing":"0000899243-21-011920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321011920/doc4.xml","form_type":"4"}},{"id":2786057,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-03-16T20:05:19.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":8404,"price":92.6437,"value":778577.6548,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold from $92.31 to $93.27 per share."}],"balance_after":99963,"source":{"system":"sec-edgar","filing":"0000899243-21-011920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321011920/doc4.xml","form_type":"4"}},{"id":2786056,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-03-16T20:05:19.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":8416,"price":91.9418,"value":773782.1888,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold from $91.30 to $92.29 per share."}],"balance_after":108367,"source":{"system":"sec-edgar","filing":"0000899243-21-011920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321011920/doc4.xml","form_type":"4"}},{"id":2786055,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-03-16T20:05:19.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":3957,"price":90.8907,"value":359654.4999,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $90.30 to $91.29 per share.  The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 6."}],"balance_after":116783,"source":{"system":"sec-edgar","filing":"0000899243-21-011920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321011920/doc4.xml","form_type":"4"}},{"id":2786054,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-03-16T20:05:19.000Z","date":"2021-03-15","kind":"exercise","acquired":false,"shares":25000,"price":2.9,"value":72500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020."}],"balance_after":120740,"source":{"system":"sec-edgar","filing":"0000899243-21-011920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321011920/doc4.xml","form_type":"4"}},{"id":2899117,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-22T23:22:14.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":6851,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in 48 equal monthly installments beginning on February 1, 2021 such that this option is fully exercisable on January 1, 2025."}],"balance_after":6851,"derivative":{"exercise_price":109.01,"expiration_date":"2031-01-20","underlying":"Common Stock","underlying_shares":6851},"source":{"system":"sec-edgar","filing":"0001209191-21-004956","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004956/doc4.xml","form_type":"4"}},{"id":2899116,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2021-01-22T23:22:14.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":18013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Award of restricted stock units (\"RSUs\") that vests with respect to the 1/4th of the underlying shares on each of January 8, 2022, January 8, 2023, January 8, 2024, and January 8, 2025."}],"balance_after":95740,"source":{"system":"sec-edgar","filing":"0001209191-21-004956","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004956/doc4.xml","form_type":"4"}},{"id":2909544,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2021-01-13T01:40:32.000Z","date":"2021-01-11","kind":"sale","acquired":false,"shares":871,"price":109.654,"value":95508.634,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the reporting person on January 8, 2020. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.19 to $110.18 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":77727,"source":{"system":"sec-edgar","filing":"0001209191-21-003340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121003340/doc4.xml","form_type":"4"}},{"id":2909543,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2021-01-13T01:40:32.000Z","date":"2021-01-11","kind":"sale","acquired":false,"shares":1051,"price":110.758,"value":116406.658,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the reporting person on January 8, 2020. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.19 to $111.18 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":78598,"source":{"system":"sec-edgar","filing":"0001209191-21-003340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121003340/doc4.xml","form_type":"4"}},{"id":2909542,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2021-01-13T01:40:32.000Z","date":"2021-01-11","kind":"sale","acquired":false,"shares":1332,"price":111.616,"value":148672.512,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the reporting person on January 8, 2020. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.19 to $112.18 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":79649,"source":{"system":"sec-edgar","filing":"0001209191-21-003340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121003340/doc4.xml","form_type":"4"}},{"id":2909541,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2021-01-13T01:40:32.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":151,"price":114.755,"value":17328.005,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 15,000 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.38 to $115.37 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":80981,"source":{"system":"sec-edgar","filing":"0001209191-21-003340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121003340/doc4.xml","form_type":"4"}},{"id":2909540,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2021-01-13T01:40:32.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":872,"price":115.799,"value":100976.728,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 15,000 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.38 to $116.37 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":81132,"source":{"system":"sec-edgar","filing":"0001209191-21-003340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121003340/doc4.xml","form_type":"4"}},{"id":2909539,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2021-01-13T01:40:32.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":2451,"price":117.154,"value":287144.454,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 15,000 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.38 to $117.37 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":82004,"source":{"system":"sec-edgar","filing":"0001209191-21-003340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121003340/doc4.xml","form_type":"4"}},{"id":2909538,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2021-01-13T01:40:32.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":2756,"price":117.599,"value":324102.844,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 15,000 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.38 to $118.37 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":84455,"source":{"system":"sec-edgar","filing":"0001209191-21-003340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121003340/doc4.xml","form_type":"4"}},{"id":2944302,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-15T21:01:17.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This option is fully vested."}],"balance_after":41156,"derivative":{"exercise_price":2.9,"expiration_date":"2026-01-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-063449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120063449/doc4.xml","form_type":"4"}},{"id":2944301,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2020-12-15T21:01:17.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":100,"price":102.75,"value":10275.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."}],"balance_after":87211,"source":{"system":"sec-edgar","filing":"0001209191-20-063449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120063449/doc4.xml","form_type":"4"}},{"id":2944300,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2020-12-15T21:01:17.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":1006,"price":102.063,"value":102675.378,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents the weighted average sale price of shares sold ranging from $101.56 to $102.42 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":87311,"source":{"system":"sec-edgar","filing":"0001209191-20-063449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120063449/doc4.xml","form_type":"4"}},{"id":2944299,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2020-12-15T21:01:17.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":400,"price":100.97,"value":40388.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sale price of shares sold ranging from $100.48 to $101.41 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":88317,"source":{"system":"sec-edgar","filing":"0001209191-20-063449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120063449/doc4.xml","form_type":"4"}},{"id":2944298,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2020-12-15T21:01:17.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":3822,"price":99.7685,"value":381315.207,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of shares sold ranging from $99.28 to $100.25 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":88717,"source":{"system":"sec-edgar","filing":"0001209191-20-063449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120063449/doc4.xml","form_type":"4"}},{"id":2944297,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2020-12-15T21:01:17.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":3148,"price":98.7969,"value":311012.6412,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of shares sold ranging from $98.28 to $99.26 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":92539,"source":{"system":"sec-edgar","filing":"0001209191-20-063449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120063449/doc4.xml","form_type":"4"}},{"id":2944296,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2020-12-15T21:01:17.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":2946,"price":97.6959,"value":287812.1214,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of shares sold ranging from $97.27 to $98.24 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":95687,"source":{"system":"sec-edgar","filing":"0001209191-20-063449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120063449/doc4.xml","form_type":"4"}},{"id":2944295,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2020-12-15T21:01:17.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":11765,"price":96.6546,"value":1137141.369,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of shares sold ranging from $96.23 to $97.21 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":98633,"source":{"system":"sec-edgar","filing":"0001209191-20-063449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120063449/doc4.xml","form_type":"4"}},{"id":2944294,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2020-12-15T21:01:17.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":1813,"price":95.8947,"value":173857.0911,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of shares sold ranging from $95.23 to $96.20 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":110398,"source":{"system":"sec-edgar","filing":"0001209191-20-063449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120063449/doc4.xml","form_type":"4"}},{"id":2944293,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2020-12-15T21:01:17.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":25000,"price":2.9,"value":72500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."}],"balance_after":112211,"source":{"system":"sec-edgar","filing":"0001209191-20-063449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120063449/doc4.xml","form_type":"4"}},{"id":3029981,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-09-16T20:02:18.000Z","date":"2020-09-14","kind":"exercise","acquired":false,"shares":21924,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option is fully vested."}],"balance_after":66156,"derivative":{"exercise_price":2.9,"expiration_date":"2026-01-07","underlying":"Common Stock","underlying_shares":21924},"source":{"system":"sec-edgar","filing":"0001209191-20-050683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/doc4.xml","form_type":"4"}},{"id":3029980,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-09-16T20:02:18.000Z","date":"2020-09-14","kind":"exercise","acquired":false,"shares":3076,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.69,"expiration_date":"2021-03-11","underlying":"Common Stock","underlying_shares":3076},"source":{"system":"sec-edgar","filing":"0001209191-20-050683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/doc4.xml","form_type":"4"}},{"id":3029979,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2020-09-16T20:02:18.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":600,"price":37.49,"value":22494.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of the shares sold ranging from $37.47 to $37.51 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":87211,"source":{"system":"sec-edgar","filing":"0001209191-20-050683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/doc4.xml","form_type":"4"}},{"id":3029978,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2020-09-16T20:02:18.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":7016,"price":36.9277,"value":259084.7432,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold ranging from $36.47 to $37.45 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":87811,"source":{"system":"sec-edgar","filing":"0001209191-20-050683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/doc4.xml","form_type":"4"}},{"id":3029977,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2020-09-16T20:02:18.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":16784,"price":36.0256,"value":604653.6704,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $35.47 to $36.46 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":94827,"source":{"system":"sec-edgar","filing":"0001209191-20-050683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/doc4.xml","form_type":"4"}},{"id":3029976,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2020-09-16T20:02:18.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":600,"price":34.6533,"value":20791.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $34.26 to $35.05 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":111611,"source":{"system":"sec-edgar","filing":"0001209191-20-050683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/doc4.xml","form_type":"4"}},{"id":3029975,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2020-09-16T20:02:18.000Z","date":"2020-09-14","kind":"exercise","acquired":true,"shares":21924,"price":2.9,"value":63579.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."}],"balance_after":112211,"source":{"system":"sec-edgar","filing":"0001209191-20-050683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/doc4.xml","form_type":"4"}},{"id":3029974,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common stock","published_at":"2020-09-16T20:02:18.000Z","date":"2020-09-14","kind":"exercise","acquired":true,"shares":3076,"price":1.69,"value":5198.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."}],"balance_after":90287,"source":{"system":"sec-edgar","filing":"0001209191-20-050683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/doc4.xml","form_type":"4"}},{"id":3291558,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-04T21:01:13.000Z","date":"2020-02-03","kind":"exercise","acquired":false,"shares":1153,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.69,"expiration_date":"2020-02-10","underlying":"Common Stock","underlying_shares":1153},"source":{"system":"sec-edgar","filing":"0001209191-20-006263","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120006263/doc4.xml","form_type":"4"}},{"id":3291557,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2020-02-04T21:01:13.000Z","date":"2020-02-03","kind":"exercise","acquired":true,"shares":1153,"price":1.69,"value":1948.57,"ownership":{"direct":true},"balance_after":87211,"source":{"system":"sec-edgar","filing":"0001209191-20-006263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120006263/doc4.xml","form_type":"4"}},{"id":3313262,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-10T21:03:08.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 1, 2020 such that this option is fully exercisable on January 1, 2024."}],"balance_after":90000,"derivative":{"exercise_price":21.99,"expiration_date":"2030-01-08","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-20-003027","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120003027/doc4.xml","form_type":"4"}},{"id":3313261,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2020-01-10T21:03:08.000Z","date":"2020-01-08","kind":"sale","acquired":false,"shares":5700,"price":20.6925,"value":117947.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 15,000 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election on November 21, 2019 by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.41 to $20.88 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":86058,"source":{"system":"sec-edgar","filing":"0001209191-20-003027","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120003027/doc4.xml","form_type":"4"}},{"id":3313260,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2020-01-10T21:03:08.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Award of restricted stock units (\"RSUs\") that vests with respect to 1/4 of the underlying shares on each of January 8, 2021, January 8, 2022, January 8, 2023, and January 8, 2024. This grant is subject to an accelerated vesting upon a change of control of the Issuer and in the event of termination of employment under certain circumstances following a change of control of the Issuer."}],"balance_after":91758,"source":{"system":"sec-edgar","filing":"0001209191-20-003027","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120003027/doc4.xml","form_type":"4"}},{"id":3392878,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-10-16T20:06:49.000Z","date":"2019-10-15","kind":"sale","acquired":false,"shares":6200,"price":14.1759,"value":87890.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 17,500 shares of Common Stock underlying restricted stock units (\"RSUs\") granted to the reporting person on October 15, 2015. This sale was made pursuant to an irrevocable election on December 18, 2018 by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.94 to $14.35 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"All remaining shares of Common Stock held by the reporting person are subject to the terms of a lock-up agreement with Jefferies LLC and Citigroup Global Markets Inc. (the \"Representatives\"), as representatives of the underwriters in the Company's public offering pursuant to a prospectus supplement dated September 11, 2019, pursuant to which the reporting person agreed, without the prior written consent of the Representatives, and subject to limited exceptions, not to sell, offer to sell, contract to sell or lend, effect any short sale, pledge, hypothecate or grant any security interest in, or otherwise transfer or dispose of, any shares of Common Stock, either directly or indirectly."}],"balance_after":66758,"source":{"system":"sec-edgar","filing":"0001209191-19-053277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919119053277/doc4.xml","form_type":"4"}},{"id":3699008,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-09T21:04:14.000Z","date":"2019-01-07","kind":"grant","acquired":true,"shares":135000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 1, 2019 such that this option is fully exercisable on January 1, 2023."}],"balance_after":135000,"derivative":{"exercise_price":16.55,"expiration_date":"2029-01-06","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001209191-19-003022","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919119003022/doc4.xml","form_type":"4"}},{"id":3699007,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26210,"kind":"person","name":"Valamehr Bahram","position":1,"cik":"0001748177","reported_name":"Valamehr Bahram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-01-09T21:04:14.000Z","date":"2019-01-07","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Award of Restricted Stock Units that vests with respect to 1/3 of the underlying shares on each of January 7, 2020, January 7, 2021, and January 7, 2022. This grant is subject to an accelerated vesting upon a change of control of the Issuer and in the event of termination of employment under certain circumstances following a change of control of the Issuer."}],"balance_after":72958,"source":{"system":"sec-edgar","filing":"0001209191-19-003022","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919119003022/doc4.xml","form_type":"4"}}]}